Evidence map›Paper›PMID 41194454›Full record

ArticleSmall methods2025

Advancing Organ-on-Chip Models With a Sacrificial Granular Hydrogel Strategy for Enhanced Permeability and Biomimicry.

Hugo R Caires, Óscar Castillo-Fernández, Núria Sima, Mariana V Magalhães, Andreu Benavent-Claró, Nil Masó-Castro, Wanlapa Roobsoong, Carmen Fernandez-Becerra, Aurora Hernández-Machado, Hernando A Del Portillo and 1 more

Abstract read
In one paragraph

Article in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hugo R Cairesi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, 4200-135, Portugal.ORCID 0000-0001-7657-7410
Óscar Castillo-FernándezMalaria and Neglected Parasitic Diseases Program, Institute for Global Health (ISGlobal), Barcelona, 08036, Spain.
Núria SimaMalaria and Neglected Parasitic Diseases Program, Institute for Global Health (ISGlobal), Barcelona, 08036, Spain.ORCID 0000-0003-4097-1402
Mariana V Magalhãesi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, 4200-135, Portugal.ORCID 0000-0002-4449-4140
Andreu Benavent-ClaróInstitute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, 08028, Spain.ORCID 0000-0001-7423-3358
Nil Masó-CastroMalaria and Neglected Parasitic Diseases Program, Institute for Global Health (ISGlobal), Barcelona, 08036, Spain.ORCID 0009-0000-1697-5927
Wanlapa RoobsoongMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.ORCID 0000-0002-1789-0439
Carmen Fernandez-BecerraMalaria and Neglected Parasitic Diseases Program, Institute for Global Health (ISGlobal), Barcelona, 08036, Spain.ORCID 0000-0001-5154-0013
Aurora Hernández-MachadoInstitute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, 08028, Spain.ORCID 0000-0002-0397-5255
Hernando A Del PortilloMalaria and Neglected Parasitic Diseases Program, Institute for Global Health (ISGlobal), Barcelona, 08036, Spain.ORCID 0000-0002-5278-3452
Cristina C Barriasi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, 4200-135, Portugal.ORCID 0000-0002-8178-6134

Funding

European Regional Development Fund (ERDF) PPBI-POCI-01-0145-FEDER-022122European Regional Development Fund (ERDF) PT-OPENSCREEN(NORTE-01-0145-FEDER-085468)Fundação para a Ciência e a Tecnologia (FCT) 2022.10184.BD.'la Caixa' Foundation LCF/PR/HR21/52410021Ministerio de Ciencia, Innovacion y Universidades AGAUR 2021-SGR-00450Ministerio de Ciencia, Innovacion y Universidades PID2022-137994NB-100Spanish Ministry of Science and Innovation (MICINN) AGAUR2021-SGR-01554)Spanish Ministry of Science and Innovation (MICINN) CEX2023-0001290-SSpanish Ministry of Science and Innovation (MICINN) MCIN/AEI/10.13039/501100011033Spanish Ministry of Science and Innovation (MICINN) PID2022-42908OB-I00
6 · The paper itself

Abstract

Infectious diseases such as malaria, leishmaniasis, and human immunodeficiency virus (HIV) involve pathogens with complex life cycles that span multiple organs, including the bone marrow (BM), a niche for latent or cryptic infections. Studying these hidden stages in patients presents significant technical and ethical challenges, underscoring the need for advanced in vitro models such as organ-on-chip (OoC) platforms. While cell-laden hydrogels can replicate tissue-like 3D-microenvironments, their small mesh size may restrict pathogen migration and cell-pathogen interactions, both critical for establishing infection on-chip. To overcome this limitation, this work develops a "reversed" granular hydrogel strategy that creates interconnected microporosity in hydrogels incorporated into organ-on-chip compartments. Sacrificial alginate (ALG) µgels are embedded as porogens in a fibrin-collagen (FIB-COL) precursor inside a custom BM-on-chip and, after crosslinking, are selectively removed by in situ enzymatic/chemical leaching to yield highly porous hydrogels (pFIB-COL). The pFIB-COL supports 3D-cultures of mesenchymal stromal cells, endothelial cells, and erythroblasts. Physical and cellular analyses show reduced flow resistance, enhanced particle and cell permeation, more uniform cell distribution and improved endothelial network formation compared with native FIB-COL. This versatile strategy is readily adaptable to other hydrogel systems, providing a valuable tool for the faithful modeling of infection processes in biomimetic 3D-microenvironments within OoC devices.

Indexed as

BiomimeticsHydrogelsLab-On-A-Chip DevicesAlginatesCollagenFibrinHumansMesenchymal Stem CellsPermeabilityPorosityAlginatesCollagenFibrinHydrogels3D modelinfection modelmicroporogen‐structured hydrogelporous hydrogelsacrificial microparticles

Identifiers

PMID41194454
PMCPMC12716228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.